STAT+: Health care features prominently in Democrats’ agenda

STAT PlusNewsletterD.C. Diagnosis Health care features prominently in Democrats’ agenda You’re reading STAT’s D.C. Diagnosis newsletter Manage alerts for this article Email this article Share this article By John WilkersonSept.

8, 2026 Washington Correspondent John Wilkerson[email protected]John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07.

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.

House Republicans canceled the last two weeks of their session in September, which means House lawmakers will have gotten at least 15 weeks off between Memorial Day and the midterms on Nov. 3. Send news tips and PTO requests to [email protected] or John_Wilkerson.07 on Signal.Advertisement House Democrats’ agenda takes shape In the week that the House was in town, a fuzzy outline of the health care agenda that Democrats are considering should they win back the House started to take form.

STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account?

Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+.

Subscribe Log In Congress, Health insurance, hospitals, Medicaid, Medicare, Policy, STAT+ Submit a correction requestReprints John Wilkerson Washington Correspondent John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07.

Newsletter The latest updates in federal health agencies, research institutes, and U.S. policy Recommended The Readout September 8, 2026 STAT Plus: FDA approves AstraZeneca breast cancer drug Exclusive September 8, 2026 STAT Plus: UnitedHealth executives shower high-ranking Democrat with donations ahead of midterms Advertisement Business September 4, 2026 STAT Plus: Top Boston hospitals clash over Medicare Advantage network after split The Readout September 4, 2026 STAT Plus: FDA takes another look at botanical drugs Biotech September 3, 2026 STAT Plus: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder Subscriber Picks